Hot Features
프리미엄
브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
기간:
그리기 모드:
| 거래량 | 0 |
|
|||||
| 뉴스 | - |
| 기업명 | 주식 심볼 | 시장 | 주식 타입 |
|---|---|---|---|
| SAB Biotherapeutics Inc | SABSW | 나스닥 | 주식 인수형 워런트 |
| 가격 변동 | 가격 변동 % | 주식 가격 | 최근 거래 시간
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.026 | 09:00:00 |
| 개장가 | 저가 | 고가 | 종가 | 전일 종가 |
|---|---|---|---|---|
| 0.026 |
| 거래횟수 | 거래량 | 평균 거래량 |
|---|---|---|
| 0 | 0 | - |
| 최근 시간 | 타입 | 수량 | 주식 가격 | 통화 |
|---|---|---|---|---|
| - | 0 | 0.026 | USD |
SAB Biotherapeutics Inc
| 시가총액 | 발행 주식 | Float | 매출 | 이익/손실 | EPS | 주가수익률 |
|---|---|---|---|---|---|---|
| 1.36M | 52.32M | - | 2.24M | -42.19M | -0.81 | - |
| 공매도 잔량 | 주당 배당금 | 배당수익률 | 배당락일 | 인사이더 B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News SAB Biotherapeutics
| Date | Time | Source | Heading |
|---|---|---|---|
| 04/04/2025 | 06:15 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 06/02/2025 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28/01/2025 | 21:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06/11/2024 | 06:41 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 09/09/2024 | 21:21 | Edgar (US Regulatory) | Form 8-K - Current report |
| 31/05/2024 | 06:15 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 21/05/2024 | 20:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21/05/2024 | 06:45 | GlobeNewswire Inc. | SAB Biotherapeutics Announces Q1 2024 Financial Results and.. |
| 21/05/2024 | 05:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 06/05/2024 | 20:15 | GlobeNewswire Inc. | SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of.. |
| 16/04/2024 | 20:15 | GlobeNewswire Inc. | SAB Biotherapeutics Provides SAB-142 Trial Update |
SABSW Historical
| 기간 | 시가 | 고가 | 저가 | VWAP | 평균 일일 거래량 | 변동 | % |
|---|---|---|---|---|---|---|---|
| 1주 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1개월 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3개월 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6개월 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1년 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3년 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5년 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
NASDAQ:SABSW -
What is the current SAB Biotherapeutics Inc share price?
The current share price of SAB Biotherapeutics Inc is US$ 0.026
How many SAB Biotherapeutics Inc shares are in issue?
SAB Biotherapeutics Inc has 52,319,000 shares in issue
What is the market cap of SAB Biotherapeutics Inc?
The market capitalisation of SAB Biotherapeutics Inc is USD 1.36M
What is the 1 year trading range for SAB Biotherapeutics Inc share price?
SAB Biotherapeutics Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of SAB Biotherapeutics Inc?
The price to earnings ratio of SAB Biotherapeutics Inc is -1.53
What is the cash to sales ratio of SAB Biotherapeutics Inc?
The cash to sales ratio of SAB Biotherapeutics Inc is 28.74
What is the reporting currency for SAB Biotherapeutics Inc?
SAB Biotherapeutics Inc reports financial results in USD
What is the latest annual turnover for SAB Biotherapeutics Inc?
The latest annual turnover of SAB Biotherapeutics Inc is USD 2.24M
What is the latest annual profit for SAB Biotherapeutics Inc?
The latest annual profit of SAB Biotherapeutics Inc is USD -42.19M
What is the registered address of SAB Biotherapeutics Inc?
The registered address for SAB Biotherapeutics Inc is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the SAB Biotherapeutics Inc website address?
The website address for SAB Biotherapeutics Inc is www.sab.bio
Which industry sector does SAB Biotherapeutics Inc operate in?
SAB Biotherapeutics Inc operates in the BLANK CHECKS sector
